These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 32797735)
1. Role of prophylactic and therapeutic red blood cell exchange in pregnancy with sickle cell disease: Maternal and perinatal outcomes. Yılmaz Baran Ş; Kozanoğlu İ; Korur A; Doğan Durdağ G; Kalaycı H; Alemdaroğlu S; Asma S; Kılıçdağ EB; Boğa C J Clin Apher; 2021 Jun; 36(3):283-290. PubMed ID: 32797735 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy. Asma S; Kozanoglu I; Tarım E; Sarıturk C; Gereklioglu C; Akdeniz A; Kasar M; Turgut NH; Yeral M; Kandemir F; Boga C; Ozdogu H Transfusion; 2015 Jan; 55(1):36-44. PubMed ID: 25070465 [TBL] [Abstract][Full Text] [Related]
3. [Management of high risk pregnancy in sickle cell disease by a strategy of prophylactic red cell transfusion or automated red cell exchange]. Driss F; Tertian G; Becquemont L; Haddad B; Cynober T; Raphael M; Tchernia G Transfus Clin Biol; 2007 Oct; 14(4):386-92. PubMed ID: 18035571 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. Koshy M; Burd L; Wallace D; Moawad A; Baron J N Engl J Med; 1988 Dec; 319(22):1447-52. PubMed ID: 3054555 [TBL] [Abstract][Full Text] [Related]
5. Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis. Vianello A; Vencato E; Cantini M; Zanconato G; Manfrin E; Zamo A; Zorzi F; Mazzi F; Martinelli N; Cavaliere E; Monari F; Venturelli D; Ferrara F; Olivieri O; De Franceschi L Transfusion; 2018 Sep; 58(9):2192-2201. PubMed ID: 29984534 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome. Howard RJ; Tuck SM; Pearson TC Br J Obstet Gynaecol; 1995 Dec; 102(12):947-51. PubMed ID: 8652484 [TBL] [Abstract][Full Text] [Related]
7. Management of sickle cell disease during pregnancy: experience in a third-level hospital and future recommendations. Montironi R; Cupaiolo R; Kadji C; Badr DA; Deleers M; Charles V; Vanderhulst J; El Kenz H; Jani JC J Matern Fetal Neonatal Med; 2022 Jun; 35(12):2345-2354. PubMed ID: 32627603 [TBL] [Abstract][Full Text] [Related]
8. Description of criteria for near miss in high-complexity obstetric population with sickle cell anemia: an observational study. Burgos Luna JM; Páez Rúa DM; Ruiz Ordoñez I; Fernández PA; Escobar Vidarte MF J Matern Fetal Neonatal Med; 2020 Mar; 33(6):941-946. PubMed ID: 30231783 [No Abstract] [Full Text] [Related]
9. Evaluation of a prophylactic transfusion program on obstetric outcomes in pregnant women with sickle cell disease: A single centre retrospective cohort study. Sobczyk O; Gottardi E; Lefebvre M; Canouï-Poitrine F; Jebali A; De Luna G; Pirenne F; Redel D; Galacteros F; Boutin E; Bartolucci P; Haddad B; Habibi A; Lecarpentier E Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():103-108. PubMed ID: 37776703 [TBL] [Abstract][Full Text] [Related]
10. The role of prophylactic transfusion on the maternal and fetal outcomes in pregnant women with sickle cell disease: A systematic review and meta-analysis. AlMoshary M; Arabdin M Medicine (Baltimore); 2024 Sep; 103(36):e39475. PubMed ID: 39252331 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis. Malinowski AK; Shehata N; D'Souza R; Kuo KH; Ward R; Shah PS; Murphy K Blood; 2015 Nov; 126(21):2424-35; quiz 2437. PubMed ID: 26302758 [TBL] [Abstract][Full Text] [Related]
12. Transfusion practices in the care of pregnant women with sickle cell disease in Ouagadougou. Zamané H; Sanou F; Kiemtoré S; Kain DP; Sawadogo AK; Bonané-Thiéba B Int J Gynaecol Obstet; 2019 Dec; 147(3):363-367. PubMed ID: 31489626 [TBL] [Abstract][Full Text] [Related]
14. Evidence for Prophylactic Transfusion during Pregnancy for Women with Sickle Cell Disease. Whittington JR; Magann EF; Ounpraseuth ST; Chang JN; Whitcombe DD; Morrison JC South Med J; 2021 Apr; 114(4):231-236. PubMed ID: 33787937 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy in the Sickle Cell Disease and Fetomaternal Outcomes in Different Sickle cell Genotypes: A Systematic Review and Meta-Analysis. Aghamolaei T; Pormehr-Yabandeh A; Hosseini Z; Roozbeh N; Arian M; Ghanbarnezhad A Ethiop J Health Sci; 2022 Jul; 32(4):849-864. PubMed ID: 35950054 [TBL] [Abstract][Full Text] [Related]